Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Eigeliene, Natalija ^a,b,c   Härkönen, Pirkko ^b,d   Erkkola, Risto ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; MEDROXYPROGESTERONE ACETATE; STEROID RECEPTOR;

ACINAR CELL; ADULT; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; EXPLANT; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MORPHOLOGY; MORPHOMETRICS; ORGAN CULTURE; POSTMENOPAUSE; TISSUE CULTURE;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; DNA FRAGMENTATION; DRUG SYNERGISM; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMEDIATE-EARLY PROTEINS; KI-67 ANTIGEN; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; NEOPLASM PROTEINS; ORGAN CULTURE TECHNIQUES; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, PROGESTERONE; STROMAL CELLS;

EID: 33750697301     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-246     Document Type: Article

References (57)

1. Black RJ, Bray F, Ferlay J, Parkin DM: Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997, 33(7):1075-1107.
2. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992, 117(12):1016-1037.
3. Henderson BE, Feigelson HS: Hormonal carcinogenesis. Carcinogenesis 2000, 21(3):427-433.
4. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer Res 1990, 50(23):7415-7421.
5. Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE: Sex steroid hormones and genetic susceptibility to breast and prostate cancer. Drug Metab Rev 1998, 30(2):421-434.
6. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 2002, 288(3):321-333.
7. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997, 350(9084):1047-1059.
8. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT: Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. Jama 2006, 295(14):1647-1657.
9. Bergkvist L, Persson I: Hormone replacement therapy and breast cancer. A review of current knowledge. Drug Saf 1996, 15(5):360-370.
10. Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L: Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997, 176(1 Pt 1):123-128.
11. Olsson H, Jernstrom H, Alm P, Kreipe H, Ingvar C, Jonsson PE, Ryden S: Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat 1996, 40(2):187-196.
12. Meyer JS: Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol 1977, 8(1):67-81.
13. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A: The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988, 58(2):163-170.
14. Going JJ, Anderson TJ, Battersby S, MacIntyre CC: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 1988, 130(1):193-204.
15. Kramer EA, Seeger H, Kramer B, Wallwiener D, Mueck AO: The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. Menopause 2005, 12(4):468-474.
16. Zhuang YH, Saaristo R, Ylikomi T: An in vitro long-term culture model for normal human mammary gland: expression and regulation of steroid receptors. Cell Tissue Res 2003, 311(2):217-226.
17. Burdall SE, Hanby AM, Lansdown MR, Speirs V: Breast cancer cell lines: friend or foe? Breast Cancer Res 2003, 5(2):89-95.
18. Stute P, Wood CE, Kaplan JR, Cline JM: Cyclic changes in the mammary gland of cynomolgus macaques. Fertil Steril 2004, 82 Suppl 3:1160-1170.
19. Isaksson E, Wang H, Sahlin L, von Schoultz B, Cline JM, von Schoultz E: Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques. Breast Cancer Res Treat 2003, 79(2):233-239.
20. Cline JM, Soderqvist G, von Schoultz E, Skoog L, von Schoultz B: Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. Breast Cancer Res Treat 1998, 48(3):221-229.
21. Levine JF, Stockdale FE: Cell-cell interactions promote mammary epithelial cell differentiation. J Cell Biol 1985, 100(5):1415-1422.
22. Gache C, Berthois Y, Martin PM, Saez S: Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture. In Vitro Cell Dev Biol Anim 1998, 34(4):347-351.
23. Ronnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 1996, 76(1):69-125.
24. Nevalainen MT, Harkonen PL, Valve EM, Ping W, Nurmi M, Martikainen PM: Hormone regulation of human prostate in organ culture. Cancer Res 1993, 53(21):5199-5207.
25. Nevalainen MT, Valve EM, Makela SI, Blauer M, Tuohimaa PJ, Harkonen PL: Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture. Endocrinology 1991, 129(2):612-622.
26. Trowell OA: The culture of mature organs in a synthetic medium. Exp Cell Res 1959, 16(1):118-147.
27. Hillman EA, Vocci MJ, Combs JW, Sanefuji H, Robbins T, Janss DH, Harris CC, Trump BF: Human breast organ culture studies. Methods Cell Biol 1980, 21B:79-106.
28. Hillman EA, Valerio MG, Halter SA, Barrett-Boone LA, Trump BF: Long-term explant culture of normal mammary epithelium. Cancer Res 1983, 43(1):245-257.
29. Hood CJ, Parham DM: A simple method of tumour culture. Pathol Res Pract 1998, 194(3):177-181.
30. Sadi MV, Barrack ER: Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy. Cancer 1991, 67(12):3065-3071.
31. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ: Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999, 84(12):4559-4565.
32. Thike AA, Chng MJ, Fook-Chong S, Tan PH: Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 2001, 33(1):21-25.
33. Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H: The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol 2002, 55(7):514-519.
34. Yu CC, Filipe MI: Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 1993, 25(12):843-853.
35. Foidart JM, Colin C, Denoo X, Desreux J, Beliard A, Fournier S, de Lignieres B: Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 1998, 69(5):963-969.
36. Laidlaw IJ, Clarke RB, Howell A, Owen AW, Potten CS, Anderson E: The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995, 136(1):164-171.
37. Clarke RB, Howell A, Anderson E: Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 1997, 45(2):121-133.
38. Kuhl H: Pharmacology of estrogens and progestogens: Influence of different routes of administration. Climacteric 2005, 8 Suppl 1:3-63.
39. Russo J, Russo IH: Development of the human breast. Maturitas 2004, 49(1):2-15.
40. Parmar H, Cunha GR: Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer 2004, 11(3):437-458.
41. Russo IH, Russo J: Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998, 3(1):49-61.
42. Berstein LM, Tsyrlina EV, Kolesnik OS, Gamajunova VB, Adlercreutz H: Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol 2000, 72(34):143-147.
43. Seeger H, Wallwiener D, Kraemer E, Mueck AO: Comparison of possible carcinogenic estradiol metabolites: Effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006, 54(1):72-77.
44. Russo J, Ao X, Grill C, Russo IH: Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 1999, 53(3):217-227.
45. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996, 93(12):5925-5930.
46. Speirs V, Skliris GP, Burdall SE, Carder PJ: Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J Clin Pathol 2002, 55(5):371-374.
47. Skliris GP, Parkes AT, Limer JL, Burdall SE, Carder PJ, Speirs V: Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol 2002, 197(2):155-162.
48. Clarke RB, Howell A, Potten CS, Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast Cancer Res 1997, 57(22):4987-4991.
49. Anderson E, Clarke RB, Howell A: Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 1998, 3(1):23-35.
50. Anderson E: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 2002, 4(5):197-201.
51. Cheng G, Li Y, Omoto Y, Wang Y, Berg T, Nord M, Vihko P, Warner M, Piao YS, Gustafsson JA: Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland. J Clin Endocrinol Metab 2005, 90(1):435-444.
52. Gustafsson JA: ERbeta scientific visions translate to clinical uses. Climacteric 2006, 9(3):156-160.
53. Herynk MH, Fuqua SA: Estrogen receptor mutations in human disease. Endocr Rev 2004, 25(6):869-898.
54. Conneely OM, Jericevic BM, Lydon JP: Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2003, 8(2):205-214.
55. Graham JD, Clarke CL: Physiological action of progesterone in target tissues. Endocr Rev 1997, 18(4):502-519.
56. Anderson E, Clarke RB: Steroid receptors and cell cycle in normal mammary epithelium. J Mammary Gland Biol Neoplasia 2004, 9(1):3-13.
57. Gustafsson JA, Warner M: Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 2000, 74(5):245-248.